16.09.24|Adiel Eithan MustakiInvestors are hopeful, but the company must now face an uphill battle in a crowded market.
04.12.23|Adiel Eithan MustakiThe Swiss conglomerate notified Epitomee that it has decided not to market its product as the clinical trial results measuring the disparity in the weight loss rate between patients who took the pill and the control group did not reach the previously agreed upon success level
04.09.23|Adiel Eithan MustakiThe company, which has not yet published the full results of its study, plans to seek FDA approval via the 510(k) pathway
16.02.20|Lilach BaumerOn Thursday, the manufacturer of Belviq weight loss drug, Eisai, announced it was withdrawing the drug from the U.S. market after a five-year trial found it increased risk of cancer by 0.6%